Atea Pharmaceuticals, Inc.
AVIRNASDAQHealthcare● Active
$4.32
+$0.07(+1.65%)
Market Cap$345717068
P/E Ratio—
52W High$6.45
52W Low$2.78
Atea Pharmaceuticals, Inc.（AVIR）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · AVIR · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.16B) | ($0.17B) | ($0.14B) | ($0.12B) | $0.12B |
| Depreciation & Amort. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Stock-Based Comp. | $0.02B | $0.05B | $0.05B | $0.05B | $0.04B |
| Change in Working Capital | $0.02B | ($0.01B) | $0.02B | ($0.05B) | ($0.25B) |
| Net Cash from Operations | ($0.13B) | ($0.14B) | ($0.09B) | ($0.12B) | ($0.09B) |
| Investing Activities | |||||
| Capital Expenditure | $0.00B | $0.00B | $0.00B | ($0.00B) | ($0.00B) |
| Purchases of Investments | ($0.28B) | ($0.46B) | ($0.56B) | ($0.55B) | $0.00B |
| Sales of Investments | $0.47B | $0.52B | $0.60B | $0.09B | $0.00B |
| Net Cash from Investing | $0.19B | $0.06B | $0.04B | ($0.46B) | ($0.00B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.03B) | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Financing | ($0.03B) | $0.00B | $0.00B | $0.00B | $0.00B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.13B) | ($0.14B) | ($0.09B) | ($0.12B) | ($0.09B) |
| FCF Margin %(computed) | — | — | — | — | -24.76% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Atea Pharmaceuticals, Inc.
关于Atea Pharmaceuticals, Inc.（AVIR）现金流量表
Atea Pharmaceuticals, Inc. 2025财年经营活动现金流($0.13B)，自由现金流($0.13B)（FCF利润率—），资本支出$0.00B。
常见问题
AVIR · 4 问Atea Pharmaceuticals, Inc. 2025财年自由现金流($0.13B)，同比up2.6%。
AVIR free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10